ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

NCT05021835 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

6200

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiovascular Risk
Chronic Kidney Disease
Inflammation

Interventions

DRUG: Ziltivekimab B
DRUG: Ziltivekimab C
DRUG: Placebo (Ziltivekimab B)
DRUG: Placebo (Ziltivekimab C)

Sponsor

Novo Nordisk A/S